This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignee: University of California. Active years: 2018-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2020
Title: Nikhil Dube: Innovator in Lipid-Peptide Conjugates
Introduction
Nikhil Dube is a prominent inventor based in Berkeley, CA. He has made significant contributions to the field of biochemistry, particularly in the development of lipid-peptide conjugates. His innovative work has led to the filing of multiple patents, showcasing his expertise and creativity in scientific research.
Latest Patents
Nikhil Dube holds 2 patents, with his latest inventions focusing on bis-polymer lipid-peptide conjugates and nanoparticles. These conjugates contain a hydrophobic block and a headgroup featuring a helical peptide along with two polymer blocks. The unique properties of these conjugates allow them to self-assemble into helix bundle subunits, which can further assemble to create micellar nanocarriers for drug cargos and other agents. The patents also disclose methods for forming these particles, highlighting their potential applications in drug delivery systems.
Career Highlights
Nikhil Dube is affiliated with the University of California, where he continues to advance his research in lipid-peptide conjugates. His work is characterized by a strong focus on innovative solutions to complex biochemical challenges. His contributions have not only enriched academic knowledge but also have practical implications in the field of medicine.
Collaborations
Nikhil has collaborated with notable colleagues such as Jessica Shu and Ting Xu. These partnerships have fostered a collaborative environment that enhances the research output and innovation in their respective fields.
Conclusion
Nikhil Dube's work in lipid-peptide conjugates exemplifies the intersection of innovation and practical application in biochemistry. His patents reflect a commitment to advancing drug delivery technologies, making a significant impact in the scientific community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
